Transmission |
Inoculation of mucous membranes, direct surface contact with droplets to mucous membranes |
Inoculation of mucous membranes, direct surface contact with droplets to mucous membranes
|
Inoculation of mucous membranes, direct contact |
Incubation |
4-6 days |
1-4 days |
Varies depending on variant
|
Presentation |
- Cough, rhinorrhea, conjunctivitis, sinusitis, otitis, tracheobronchitis, wheezing
- Exacerbation of chronic pulmonary diseases
- Acute respiratory failure in severe cases
|
- Abrupt onset of fever, nonproductive cough, body aches, malaise, nausea, congestion, sore throat, headache
- Vomiting and diarrhea rare in adults
|
- Fever, chills, cough, fatigue, shortness of breath, headache, body aches, congestion, runny nose, loss of taste or smell, vomiting or diarrhea
|
Testing |
Multipathogen PCR, rapid antigen testing, viral culture
|
Molecular assay, multipathogen PCR, antigen detection assay
|
Nucleic acid amplification testing (NAAT), antigen testing |
Treatment |
Symptom management: oxygen, bronchodilators, antipyretics
|
Supportive care: antipyretics, analgesics, hydration; antiviral treatment may be indicated
|
NIH Guideline for Treatment for Hospitalized Adults
NIH Guideline for Treatment for Non-Hospitalized Adults
|
Prevention of Severe Illness |
- No vaccine currently available
- Handwashing, masking, social distancing
|
- Vaccination
- Handwashing, masking, social distancing
|
- Vaccination
- Handwashing, masking, social distancing
|
Precautions |
Airborne
|
Droplet |
Airborne |